JW (Cayman) Therapeutics Co. Ltd (JWCTF)
USD 0.17
(0.0%)
USD 0.17
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -398.41 Million | -536.72 Million | -561.19 Million | -261 Million | -188.92 Million | -106.22 Million |
| Net Income | -767.99 Million | -846.13 Million | -702.32 Million | -1.66 Billion | -633.25 Million | -272.61 Million |
| Depreciation & Amortization | 99.83 Million | 87.07 Million | 48.22 Million | 23.59 Million | 17.3 Million | 5.1 Million |
| Deferred income taxes | - | 174.68 Million | -42.73 Million | 38.28 Million | 302.15 Million | - |
| Stock-based compensation | 34.96 Million | 82.5 Million | 89.37 Million | 134.25 Million | 15.44 Million | - |
| Change in working capital | 3.18 Million | -25.09 Million | 49.78 Million | 16.67 Million | -18.87 Million | -195 Thousand |
| Other non-cash items | -21.61 Million | -9.74 Million | -3.51 Million | 1.19 Billion | 128.31 Million | 161.47 Million |
| Investing Cash Flow | 9.9 Million | -124.08 Million | -137.13 Million | -91.9 Million | -117.55 Million | -44.14 Million |
| Investments in PPE | -14.58 Million | -100.58 Million | -137.13 Million | -137.21 Million | -114.06 Million | -44.14 Million |
| Acquisitions | - | - | - | 45.3 Million | - | - |
| Investment purchases | - | -23.55 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 22.31 Million | 52 Thousand | -64.04 Million | -12.97 Million | -3.48 Million | -501 Thousand |
| Financing Cash Flow | 275 Thousand | 112.35 Million | -30.62 Million | 2.85 Billion | 414.04 Million | 249.82 Million |
| Debt repayment | -27.7 Million | -100 Million | -13.02 Million | -37.38 Million | -40.05 Million | -7.41 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 27 Thousand | 94 Thousand | 697 Thousand | 2.14 Billion | - | - |
| Other Financing Activities | -12.38 Million | 212.26 Million | -31.31 Million | 719.21 Million | 454.1 Million | 249.82 Million |
| Accounts receivables | 5.3 Million | -5.3 Million | - | - | - | - |
| Accounts payables | - | 5.3 Million | - | - | - | - |
| Inventory | 5.38 Million | -8.75 Million | -28.78 Million | -955 Thousand | - | - |
| Other working capital | -7.49 Million | -16.33 Million | 78.56 Million | 17.62 Million | -18.87 Million | -195 Thousand |
| Cash at beginning of period | 1.38 Billion | 1.83 Billion | 2.63 Billion | 254.86 Million | 133.66 Million | 21.2 Million |
| Cash at end of period | 1 Billion | 1.38 Billion | 1.83 Billion | 2.63 Billion | 254.86 Million | 133.66 Million |
| Capital Expenditure | -14.58 Million | -100.58 Million | -137.13 Million | -137.21 Million | -114.06 Million | -44.14 Million |
| Effect of forex changes on cash | 10.81 Million | 97.38 Million | -67.25 Million | -130.78 Million | 13.63 Million | 13.01 Million |
| Net cash flow / Change in cash | -377.42 Million | -451.06 Million | -796.19 Million | 2.37 Billion | 121.2 Million | 112.46 Million |
| Free Cash Flow | -412.99 Million | -637.3 Million | -698.32 Million | -398.22 Million | -302.98 Million | -150.37 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.53 Million | -16.63 Million | -767.99 Million | -27.3 Million | -26.54 Million | -54.88 Million |
| Depreciation & Amortization | 3.22 Million | 3.24 Million | 99.83 Million | 3.11 Million | 3.03 Million | 6.93 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.27 Million | 1.28 Million | 34.96 Million | 212.1 Thousand | 206.2 Thousand | 2.2 Million |
| Change in working capital | - | - | 3.18 Million | 224.57 Thousand | 218.32 Thousand | - |
| Other non-cash items | -920.75 Thousand | -926.73 Thousand | -21.61 Million | 12.45 Million | 12.1 Million | 26.83 Million |
| Investing Cash Flow | -890.55 Thousand | -896.33 Thousand | 9.9 Million | -536.29 Thousand | -521.36 Thousand | 2.52 Million |
| Investments in PPE | -197.38 Thousand | -198.67 Thousand | -14.58 Million | -397.86 Thousand | -386.79 Thousand | -993.04 Thousand |
| Acquisitions | - | - | - | 11.61 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -693.16 Thousand | -697.66 Thousand | 22.31 Million | -138.42 Thousand | -134.57 Thousand | 3.52 Million |
| Financing Cash Flow | 3.92 Million | 3.95 Million | 275 Thousand | -6.24 Million | -6.06 Million | 13.47 Million |
| Debt repayment | -9.86 Million | - | -27.7 Million | -11.01 Million | - | -14.78 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 37.18 Thousand | - | 27 Thousand | -174.97 | - | 3895.44 |
| Other Financing Activities | 3.92 Million | 3.95 Million | -12.38 Million | -6.24 Million | -6.06 Million | 6.12 Million |
| Accounts receivables | - | - | 5.3 Million | 373.7 Thousand | 363.3 Thousand | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | 5.38 Million | 379.06 Thousand | 368.51 Thousand | - |
| Other working capital | - | - | -7.49 Million | -528.19 Thousand | -513.49 Thousand | - |
| Cash at beginning of period | 141.79 Million | - | 1.38 Billion | 175.18 Million | - | 198.81 Million |
| Cash at end of period | 119.55 Million | -9.47 Million | 1 Billion | 141.79 Million | -18.28 Million | 175.18 Million |
| Capital Expenditure | -197.38 Thousand | -198.67 Thousand | -14.58 Million | -397.86 Thousand | -386.79 Thousand | -993.04 Thousand |
| Effect of forex changes on cash | 496.8 Thousand | 500.03 Thousand | 10.81 Million | -729.94 Thousand | -709.62 Thousand | 1.45 Million |
| Net cash flow / Change in cash | -22.24 Million | -9.47 Million | -377.42 Million | -33.38 Million | -18.28 Million | -23.63 Million |
| Free Cash Flow | -13.14 Million | -13.23 Million | -412.99 Million | -11.69 Million | -11.37 Million | -35.98 Million |
GS-PD
AMIC
BYSD
PUCCF
2488
PDNLA